Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Accenture
Johnson and Johnson
McKesson
Chinese Patent Office
Colorcon
Boehringer Ingelheim
Deloitte
Julphar

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011695

« Back to Dashboard

NDA 011695 describes PHENY-PAS-TEBAMIN, which is a drug marketed by Pharm Res Assoc and is included in one NDA. Additional details are available on the PHENY-PAS-TEBAMIN profile page.

The generic ingredient in PHENY-PAS-TEBAMIN is phenyl aminosalicylate. There are two hundred and three drug master file entries for this compound. Additional details are available on the phenyl aminosalicylate profile page.
Summary for 011695
Tradename:PHENY-PAS-TEBAMIN
Applicant:Pharm Res Assoc
Ingredient:phenyl aminosalicylate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;ORALStrength50%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cerilliant
Fish and Richardson
Harvard Business School
Deloitte
Cipla
Chubb
Teva
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot